It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ANGO’s FA Score shows that 0 FA rating(s) are green whileFANG’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ANGO’s TA Score shows that 3 TA indicator(s) are bullish while FANG’s TA Score has 3 bullish TA indicator(s).
ANGO (@Medical Specialties) experienced а -5.77% price change this week, while FANG (@Oil & Gas Production) price change was -4.09% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.00%. For the same industry, the average monthly price growth was +1.59%, and the average quarterly price growth was -1.40%.
The average weekly price growth across all stocks in the @Oil & Gas Production industry was -1.24%. For the same industry, the average monthly price growth was +3.26%, and the average quarterly price growth was -0.52%.
ANGO is expected to report earnings on Oct 02, 2025.
FANG is expected to report earnings on Nov 10, 2025.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Oil & Gas Production (-1.24% weekly)The oil and gas production segment includes companies that specialize in exploration, development, and production of oil and natural gas. These companies are focused on upstream operations. Companies typically identify deposits, drill wells, and extract raw materials from underground. The industry also includes related services like rig operations, feasibility studies, machinery rentals etc. Several operators in this industry work with various types of contractors such as engineering procurement and construction contractors, as well as with joint-venture partners and oil field service companies. Oil and gas often involves large fixed costs of production; so, declining crude oil prices, for example, is a potential negative for this industry. Conoco Phillips, EOG Resources, Inc. and Pioneer Natural Resources Company are some examples of companies operating in this space.
ANGO | FANG | ANGO / FANG | |
Capitalization | 234M | 35.6B | 1% |
EBITDA | -28.49M | 6.17B | -0% |
Gain YTD | -5.568 | -14.656 | 38% |
P/E Ratio | 44.84 | 11.50 | 390% |
Revenue | 330M | 8.34B | 4% |
Total Cash | 60.9M | 582M | 10% |
Total Debt | 4.73M | 6.8B | 0% |
ANGO | FANG | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 52 | 59 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 72 Overvalued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 36 | |
SMR RATING 1..100 | 94 | 100 | |
PRICE GROWTH RATING 1..100 | 62 | 63 | |
P/E GROWTH RATING 1..100 | 59 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FANG's Valuation (50) in the Oil And Gas Production industry is in the same range as ANGO (72) in the Medical Specialties industry. This means that FANG’s stock grew similarly to ANGO’s over the last 12 months.
FANG's Profit vs Risk Rating (36) in the Oil And Gas Production industry is somewhat better than the same rating for ANGO (100) in the Medical Specialties industry. This means that FANG’s stock grew somewhat faster than ANGO’s over the last 12 months.
ANGO's SMR Rating (94) in the Medical Specialties industry is in the same range as FANG (100) in the Oil And Gas Production industry. This means that ANGO’s stock grew similarly to FANG’s over the last 12 months.
ANGO's Price Growth Rating (62) in the Medical Specialties industry is in the same range as FANG (63) in the Oil And Gas Production industry. This means that ANGO’s stock grew similarly to FANG’s over the last 12 months.
ANGO's P/E Growth Rating (59) in the Medical Specialties industry is somewhat better than the same rating for FANG (100) in the Oil And Gas Production industry. This means that ANGO’s stock grew somewhat faster than FANG’s over the last 12 months.
ANGO | FANG | |
---|---|---|
RSI ODDS (%) | 2 days ago77% | 1 day ago81% |
Stochastic ODDS (%) | 2 days ago81% | 1 day ago69% |
Momentum ODDS (%) | 2 days ago74% | 1 day ago74% |
MACD ODDS (%) | 2 days ago71% | 1 day ago64% |
TrendWeek ODDS (%) | 2 days ago78% | 1 day ago67% |
TrendMonth ODDS (%) | 2 days ago73% | 1 day ago68% |
Advances ODDS (%) | 21 days ago77% | 5 days ago72% |
Declines ODDS (%) | 5 days ago71% | 1 day ago64% |
BollingerBands ODDS (%) | N/A | 1 day ago75% |
Aroon ODDS (%) | 2 days ago76% | 1 day ago68% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MANA | 2.63 | 0.04 | +1.58% |
Grayscale Decentraland Trust (MANA) | |||
IBDT | 25.25 | -0.03 | -0.10% |
iShares iBonds Dec 2028 Term Corp ETF | |||
IBII | 25.60 | -0.08 | -0.30% |
iShares iBonds Oct 2032 Term Tips ETF | |||
HPI | 15.95 | -0.06 | -0.37% |
John Hancock Preferred Income Fund | |||
IEUS | 66.64 | -0.80 | -1.19% |
iShares MSCI Europe Small-Cap ETF |
A.I.dvisor indicates that over the last year, ANGO has been loosely correlated with STRRP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANGO jumps, then STRRP could also see price increases.
Ticker / NAME | Correlation To ANGO | 1D Price Change % | ||
---|---|---|---|---|
ANGO | 100% | -10.18% | ||
STRRP - ANGO | 48% Loosely correlated | -0.22% | ||
MXCT - ANGO | 38% Loosely correlated | -5.80% | ||
RGEN - ANGO | 37% Loosely correlated | -2.66% | ||
ICUI - ANGO | 37% Loosely correlated | -3.33% | ||
NVST - ANGO | 36% Loosely correlated | -1.10% | ||
More |